Despite the effectiveness of the newer generation of anti-obesity drugs—called GLP-1 receptor agonists—few can tolerate them in the long run. A new study, published in the journal Obesity, reveals that of people prescribed weight-loss drugs, just 44% were still taking them after three months and only 19% after one year.
Leave A Comment